Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial.
Lancet. 2019 May 4;393(10183):1819-1830. doi: 10.1016/S0140-6736(18)32409-7. Epub 2019 Apr 4.
Lancet. 2019.
PMID: 30955977
Clinical Trial.
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study.
de Castro G Jr, Kudaba I, Wu YL, Lopes G, Kowalski DM, Turna HZ, Caglevic C, Zhang L, Karaszewska B, Laktionov KK, Srimuninnimit V, Bondarenko I, Kubota K, Mukherjee R, Lin J, Souza F, Mok TSK, Cho BC.
de Castro G Jr, et al. Among authors: turna hz.
J Clin Oncol. 2023 Apr 10;41(11):1986-1991. doi: 10.1200/JCO.21.02885. Epub 2022 Oct 28.
J Clin Oncol. 2023.
PMID: 36306479
Free PMC article.
Clinical Trial.
Item in Clipboard
Associations of tissue tumor mutational burden and mutational status with clinical outcomes in KEYNOTE-042: pembrolizumab versus chemotherapy for advanced PD-L1-positive NSCLC.
Mok TSK, Lopes G, Cho BC, Kowalski DM, Kasahara K, Wu YL, de Castro G Jr, Turna HZ, Cristescu R, Aurora-Garg D, Loboda A, Lunceford J, Kobie J, Ayers M, Pietanza MC, Piperdi B, Herbst RS.
Mok TSK, et al. Among authors: turna hz.
Ann Oncol. 2023 Apr;34(4):377-388. doi: 10.1016/j.annonc.2023.01.011. Epub 2023 Jan 25.
Ann Oncol. 2023.
PMID: 36709038
Free article.
Item in Clipboard
The Predictive Importance of Body Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer.
Emirzeoglu L, Arici S, Sahin AB, Ocak B, Ak N, Ay S, Mammadov E, Turna H, Bilici A.
Emirzeoglu L, et al.
Breast Care (Basel). 2023 Feb;18(1):42-48. doi: 10.1159/000526732. Epub 2022 Sep 14.
Breast Care (Basel). 2023.
PMID: 36876171
Free PMC article.
Item in Clipboard
The effects of low HER2 expression on survival in patients with metastatic breast cancer treated with CDK 4/6 inhibitors: a multicenter retrospective study.
Guliyev M, Şen GA, Gültürk İ, Majidova N, Akdağ G, Ahadzade A, Turna H, Demirci NS.
Guliyev M, et al.
Breast Cancer Res Treat. 2024 Mar 25. doi: 10.1007/s10549-024-07291-0. Online ahead of print.
Breast Cancer Res Treat. 2024.
PMID: 38526689
Item in Clipboard
Cite
Cite